Congratulations to our co-founder Ranjit Bindra!
Listen to the newest episode of the BioWorld Insider podcast: https://lnkd.in/ewqWKnpZ Modifi Bio Ranjit Bindra BioWorld News #biotech #pharma
关于我们
Alphina Therapeutics is a biotechnology company focused on precision medicine in cancer
- 网站
-
https://www.alphinatx.com
Alphina Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- New Haven，CT
- 类型
- 私人持股
- 创立
- 2020
地点
-
主要
获取路线
US，CT，New Haven
Alphina Therapeutics员工
-
Daniel Wagner
Early Stage Life Science Investor and Board Member
-
Nick Galli
CEO at Alphina Therapeutics
-
Josh Spurrier
Senior Scientist at Alphina Therapeutics
-
Sandra Lobo
Strategy and Alliance Development and Management| New Drug/Medical Device/Molecular Diagnostic Product Development and Launch
动态
-
Alphina Therapeutics appoints Nick Galli as its new CEO and member of the board of directors. With nearly 20 years of pharmaceutical and biotech experience, Galli will help advance the company's mission to develop breakthrough oncology therapies for cancer patients. Read full announcement here: https://lnkd.in/grViydv5 #oncology #cancertechnology #CEOnews #highcape
-
Connecticut Innovations has played an integral role in each of our startups, Cybrexa Therapeutics, Alphina Therapeutics, and Modifi Bio! CT is lucky to have such an ardent supporter of early-stage biotech, thank you again for believing in us ???????? Ned Lamont City of New Haven Greater New Haven Bioscience Collaborative: A Regional Sector Partnership BioCT
#NEWS: Modifi Bio today announced its acquisition by Merck.?We are honored to have Merck recognize the potential of our science and novel preclinical compounds designed to exploit DNA cancer repair defects, a frequent hallmark of tumor cells and a major cause of resistance to cancer therapy. We believe Merck is well positioned to continue our pursuit to change the oncology treatment paradigm for cancer patients with glioblastoma and other tumors. Thank you to our key investors HighCape Capital, Connecticut Innovations, Yale Ventures, BrightEdge - American Cancer Society ,?National Brain Tumor Society’s Brain Tumor Investment Fund, and Sontag Innovation Fund. Read more here:??https://lnkd.in/dM4q_e2U #OncologyTreatment?#ModifiBio?#Glioblastoma?#CTbiotech?#DDR #Merck
Modifi Biosciences Acquired by Merck
modifibio.com
-
Very excited to welcome Nick Galli as CEO of one of our latest startups, Alphina Therapeutics! https://lnkd.in/e47yCiyf
Alphina Therapeutics Appoints Veteran Biotech Executive, Nick Galli, as Chief Executive Officer
prnewswire.com
-
We’re #hiring. Know anyone who might be interested? #Alphina #ElmCityBio
-
?? Exciting News! We're thrilled to announce Nicholas Galli as our new CEO and Barbara Fox as our Board Chair Join us in welcoming them to the team! #Welcome #Alphina Therapeutics https://lnkd.in/grViydv5
Alphina Therapeutics Appoints Veteran Biotech Executive, Nick Galli, as Chief Executive Officer
prnewswire.com
-
We're #hiring a new Director, Corporate Development (Associate Director/Director/Sr. Director) in New Haven, Connecticut. Apply today or share this post with your network.
-
We're #hiring a new Head of Biology and Pharmacology (Director/Sr. Director) in New Haven, Connecticut. Apply today on our website or share this post with your network.